Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reduction in the mean number of Plasmodium falciparum genotypes in Gambian children immunized with the malaria vaccine SPf66.

Transactions of the Royal Society of Tropical Medicine and Hygiene - 1 Feb 1999

Haywood M, Conway D J, Weiss H, Metzger W, D'Alessandro U, Snounou G, Targett G, Greenwood B

Abstract excerpt

SPf66, a synthetic peptide Plasmodium falciparum vaccine, did not protect young Gambian children against clinical attacks of malaria. Nevertheless, Gambian children who had been vaccinated with SPf66 and who were parasitaemic at the end of the first malaria transmission season after vaccination had significantly fewer detectable P. falciparum genotypes than control children, as determined by polymerase chain...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Protozoan
Share to Antigens, Surface

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gambia

Share to Malaria, Falciparum

Share to Malaria Vaccines

Share to Merozoite Surface Protein 1

Share to Parasitemia

Share to Plasmodium falciparum

Source

Identifiers

PMID: 10450429
DOI: 10.1016/s0035-9203(99)90330-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Reduction in the mean number of Plasmodium falciparum genotypes in Gambian children immunized with the malaria vaccine SPf66.PMID 10450429Read ↗

Analysis of multiple Plasmodium falciparum infections in Tanzanian children during the phase III trial of the malaria vaccine SPf66.Semantic proximity Read ↗

Protective efficacy of the RTS,S/AS02 Plasmodium falciparum malaria vaccine is not strain specific.Semantic proximity Read ↗

Identification of frequently recognized dimorphic T-cell epitopes in plasmodium falciparum merozoite surface protein-1 in West and East Africans: lack of correlation of immune recognition and allelic prevalence.Semantic proximity Read ↗

RTS,S/AS02A Malaria Vaccine Does Not Induce Parasite CSP T Cell Epitope Selection and Reduces Multiplicity of InfectionSemantic proximity Read ↗

Evidence of HLA class II association with antibody response against the malaria vaccine SPF66 in a naturally exposed population.Semantic proximity Read ↗

Morbidity from malaria and immune responses to defined Plasmodium falciparum antigens in children with sickle cell trait in The Gambia.Semantic proximity Read ↗

Limited variation in vaccine candidate Plasmodium falciparum Merozoite Surface Protein-6 over multiple transmission seasons.Semantic proximity Read ↗

Plasmodium falciparum msp1, msp2 and glurp allele frequency and diversity in sub-Saharan Africa.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.